SCHEMBL268049

SCHEMBL268049

Cc1ccc(NC(=O)c2ccnn2C(C)C)nc1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN10A Q9Y5Y9 10/20 0.47
SCN5A Q14524 2/20 0.42
SCN9A Q15858 2/20 0.42
SCN1A P35498 1/20 0.42
NR3C2 P08235 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
IL17A Q16552 1/20 0.36
ALDH1A1 P00352 2/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ABL1 P00519 1/20 0.34
SCN2A Q99250 1/20 0.33
SCN3A Q9NY46 1/20 0.33
FLT1 P17948 1/20 0.33
KDR P35968 1/20 0.33
GRM5 P41594 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL263720 0.86 SCN10A (0.46) SCN10ASCN5ASCN9ASCN1ANR3C2
SCHEMBL263607 0.80 SCN10A (0.76) SCN10ASCN5ASCN9ASCN1ANR3C2
SCHEMBL262478 0.77 SCN10A (0.67) SCN10ASCN5ASCN9ASCN1ANR3C2
SCHEMBL263785 0.75 SCN10A (0.78) SCN10ASCN5ASCN9ASCN1AALDH1A1
SCHEMBL263924 0.75 SCN10A (0.78) SCN10ASCN5ASCN9ASCN1ANR3C2
SCHEMBL14237589 0.73 SCN10A (0.63) SCN10ASCN5ASCN9ASCN1AABL1
SCHEMBL22549347 0.72 BRD4 (0.42) NR3C2NPC1RAB9ACYP1A2CYP2D6
SCHEMBL23135608 0.71 L3MBTL1 (0.44) NR3C2NPC1RAB9AIL17AALDH1A1
SCHEMBL22303967 0.70 IL17A (0.42) NR3C2NPC1RAB9ACYP1A2CYP2C19
SCHEMBL262561 0.69 SCN10A (0.63) SCN10ASCN5ASCN9ASCN1ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8134007-B2 Pyridine derivatives PFIZER INC. (US) 2012-03-13 US disclosed
US-8134007-B2 Pyridine derivatives PFIZER INC. (US) 2012-03-13 US disclosed
US-20090048306-A1 PYRIDINE DERIVATIVES PFIZER, INC. (US) 2009-02-19 US disclosed
US-20090048306-A1 PYRIDINE DERIVATIVES PFIZER, INC. (US) 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048306-A1 PYRIDINE DERIVATIVES SDHA, P2RX4, P2RX3 SCN10A 358/4885SCN5A 157/4885SCN9A 491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.